Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Perspective

Pyolytics: A Step Forward to Address Respiratory Hypoxia in Coronavirus Infection

Author(s): Ilnur Yagudin and Darya Suntsova*

Volume 22, Issue 4, 2024

Published on: 13 February, 2024

Article ID: e130224226944 Pages: 3

DOI: 10.2174/0122113525287737240201050550

Price: $65

Abstract

Respiratory failure and increasing hypoxia in the era of coronavirus infection is the cause of fatal outcomes in patients with SARS. The bronchoalveolar obstruction prevents the normal passage of air, resulting in decreased oxygenation. The available methods of oxygenation (ECMO) are often not cost-effective and are not readily available in pandemic settings. Hence, the search for alternatives has prompted the discovery of a new pharmacological group - pyolytics, the use of which is very promising due to its simplicity and availability.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy